Siegfried Holding AG is a Swiss pharmaceutical company with a low ESG risk rating score of 16.4. Specializing in primary and secondary drug manufacturing, Siegfried develops and manufactures active pharmaceutical ingredients, intermediates, and controlled substances for pharmaceutical clients. The company also offers finished dosage forms, including sterile fillings. Siegfried provides a wide range of complex oral and sterile formulations of drug products for custom development and manufacturing, along with licensing opportunities.